The importance of preclinical trial timing - a potential reason for the disconnect between mouse studies and human clinical trials in ALS

CNS Neurosci Ther. 2012 Sep;18(9):791-3. doi: 10.1111/j.1755-5949.2012.00358.x. Epub 2012 Jun 19.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Amyotrophic Lateral Sclerosis / pathology
  • Animals
  • Anti-Bacterial Agents / administration & dosage*
  • Antioxidants / administration & dosage
  • Ceftriaxone / administration & dosage*
  • Disease Models, Animal
  • Disease Progression
  • Drug Evaluation, Preclinical / methods*
  • Drug Therapy, Combination
  • Humans
  • Mice
  • Mice, Transgenic
  • Minocycline / administration & dosage*
  • Research Design
  • Superoxide Dismutase
  • Treatment Outcome
  • Vitamin E / administration & dosage

Substances

  • Anti-Bacterial Agents
  • Antioxidants
  • Vitamin E
  • Ceftriaxone
  • Superoxide Dismutase
  • superoxide dismutase 2
  • Minocycline